Geyer CR - Search Results

1

EPHB6 augments both development and drug sensitivity of triple-negative breast cancer tumours.

Toosi BM, El Zawily A, Truitt L, Shannon M, Allonby O, Babu M, DeCoteau J, Mousseau D, Ali M, Freywald T, Gall A, Vizeacoumar FS, Kirzinger MW, Geyer CR, Anderson DH, Kim T, Welm AL, Siegel P, Vizeacoumar FJ, Kusalik A, Freywald A. Toosi BM, et al. Among authors: geyer cr. Oncogene. 2018 Jul;37(30):4073-4093. doi: 10.1038/s41388-018-0228-x. Epub 2018 Apr 27. Oncogene. 2018. PMID: 29700392 Free PMC article.

2

5-Aza-2'-deoxycytidine (decitabine) can relieve p21WAF1 repression in human acute myeloid leukemia by a mechanism involving release of histone deacetylase 1 (HDAC1) without requiring p21WAF1 promoter demethylation.

Scott SA, Dong WF, Ichinohasama R, Hirsch C, Sheridan D, Sanche SE, Geyer CR, Decoteau JF. Scott SA, et al. Among authors: geyer cr. Leuk Res. 2006 Jan;30(1):69-76. doi: 10.1016/j.leukres.2005.05.010. Epub 2005 Jul 25. Leuk Res. 2006. PMID: 16043219

3

RIZ1 repression is associated with insulin-like growth factor-1 signaling activation in chronic myeloid leukemia cell lines.

Pastural E, Takahashi N, Dong WF, Bainbridge M, Hull A, Pearson D, Huang S, Lowsky R, DeCoteau JF, Geyer CR. Pastural E, et al. Among authors: geyer cr. Oncogene. 2007 Mar 8;26(11):1586-94. doi: 10.1038/sj.onc.1209959. Epub 2006 Sep 4. Oncogene. 2007. PMID: 16953217

4

Bcr-Abl induces autocrine IGF-1 signaling.

Lakshmikuttyamma A, Pastural E, Takahashi N, Sawada K, Sheridan DP, DeCoteau JF, Geyer CR. Lakshmikuttyamma A, et al. Among authors: geyer cr. Oncogene. 2008 Jun 19;27(27):3831-44. doi: 10.1038/onc.2008.8. Epub 2008 Feb 4. Oncogene. 2008. PMID: 18246120

5

RIZ1 is potential CML tumor suppressor that is down-regulated during disease progression.

Lakshmikuttyamma A, Takahashi N, Pastural E, Torlakovic E, Amin HM, Garcia-Manero G, Voralia M, Czader M, DeCoteau JF, Geyer CR. Lakshmikuttyamma A, et al. Among authors: geyer cr. J Hematol Oncol. 2009 Jul 14;2:28. doi: 10.1186/1756-8722-2-28. J Hematol Oncol. 2009. PMID: 19602237 Free PMC article.

6

Loss of imprinting of the insulin-like growth factor II (IGF2) gene in esophageal normal and adenocarcinoma tissues.

Zhao R, DeCoteau JF, Geyer CR, Gao M, Cui H, Casson AG. Zhao R, et al. Among authors: geyer cr. Carcinogenesis. 2009 Dec;30(12):2117-22. doi: 10.1093/carcin/bgp254. Carcinogenesis. 2009. PMID: 19843644

7

Reexpression of epigenetically silenced AML tumor suppressor genes by SUV39H1 inhibition.

Lakshmikuttyamma A, Scott SA, DeCoteau JF, Geyer CR. Lakshmikuttyamma A, et al. Among authors: geyer cr. Oncogene. 2010 Jan 28;29(4):576-88. doi: 10.1038/onc.2009.361. Epub 2009 Nov 2. Oncogene. 2010. PMID: 19881540

8

A genetic screen for isolating "lariat" Peptide inhibitors of protein function.

Barreto K, Bharathikumar VM, Ricardo A, DeCoteau JF, Luo Y, Geyer CR. Barreto K, et al. Among authors: geyer cr. Chem Biol. 2009 Nov 25;16(11):1148-57. doi: 10.1016/j.chembiol.2009.10.012. Chem Biol. 2009. PMID: 19942138

9

Yeast two-hybrid screening of cyclic peptide libraries using a combination of random and PI-deconvolution pooling strategies.

Barreto K, Aparicio A, Bharathikumar VM, DeCoteau JF, Geyer CR. Barreto K, et al. Among authors: geyer cr. Protein Eng Des Sel. 2012 Sep;25(9):453-64. doi: 10.1093/protein/gzs029. Epub 2012 Jul 4. Protein Eng Des Sel. 2012. PMID: 22763264

10

Allosteric lariat peptide inhibitors of Abl kinase.

Bharathikumar VM, Barreto K, Decoteau JF, Geyer CR. Bharathikumar VM, et al. Among authors: geyer cr. Chembiochem. 2013 Nov 4;14(16):2119-25. doi: 10.1002/cbic.201300253. Epub 2013 Sep 12. Chembiochem. 2013. PMID: 24030821

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

58 results

Search Page